BIT 2.22% 4.6¢ biotron limited

$10 Billion Deal, page-12473

  1. 579 Posts.
    lightbulb Created with Sketch. 88
    Hry

    ASX disclosure

    Re prelims per above successful indication- But no point inferring that results were not good sinply bcs mgt didn't say the C word.

    Presumably hard for them to do so at this stage bcs ino

    1) prelim
    2) do these tests need to be extrapolated? Ie lets say it cleared 50% and reduced inflammation by 50% ... would it be 99 9% after 2 years, higher dosage, combined with some for of adjutant? Does it need to do much better than say 30 or 40% to be of value?

    Per MM theres some specific areas of improvement that ino would see this stock commercialise in near term eg HAND (dinentia issue) and reduces inflammation easing burden of immune system.

    Had a former colleague die over night after nearly beating leukaemia from a bacteria infection due to immunity being shot from chemo. 50's. Anecdotally special oncology drug was circa 250k

    Doesnt need to be a 'cure' to get commercialised imo

    So, whilst I appreciate that the prelims are not definitive. Any assumption without full scientific consideration wont deter me from this when management says new class of drug in same context as positive results.

    Lets not forget ppl are on the cart drugs for life atm

    DYOR

    Last edited by Pseudoname1: 11/05/24
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
0.001(2.22%)
Mkt cap ! $41.50M
Open High Low Value Volume
4.4¢ 4.7¢ 4.4¢ $31.64K 708.3K

Buyers (Bids)

No. Vol. Price($)
4 259000 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 17361 1
View Market Depth
Last trade - 14.10pm 21/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.